2020
DOI: 10.1007/s12094-020-02445-0
|View full text |Cite|
|
Sign up to set email alerts
|

CLIC1 knockout inhibits invasion and migration of gastric cancer by upregulating AMOT-p130 expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
8
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 24 publications
1
8
0
Order By: Relevance
“…In our study, CLIC1 was expressed with the highest score of 3 in all the LM cases, except one. In gastric cancer, the involvement of CLIC1 in metastatic progression was observed by reducing AMOT-p130 expression [34]. Scores of 2 and 3 in LM were found in the present study.…”
Section: Discussionsupporting
confidence: 61%
“…In our study, CLIC1 was expressed with the highest score of 3 in all the LM cases, except one. In gastric cancer, the involvement of CLIC1 in metastatic progression was observed by reducing AMOT-p130 expression [34]. Scores of 2 and 3 in LM were found in the present study.…”
Section: Discussionsupporting
confidence: 61%
“…Qiu, Y. et al. found that CLIC1 knockout inhibits the invasion and migration of gastric cancer by upregulating AMOT-p130 expression ( 54 ). In cell proliferation, CLIC1 can auto-transmit from the cytoplasm to the plasma membrane without transport vesicles ( 55 ).…”
Section: Discussionmentioning
confidence: 99%
“…In particular, the Ubiquitin C-terminal Hydrolase L1 (UCH-L1), a member of the deubiquitinase family involved in processing ubiquitin precursors and in regulating angiogenesis ( 63 ), and whose up-regulation has previously been demonstrated to enhance cell invasion/metastasis ( 64 , 65 ), and increase multidrug resistance in breast cancer ( 66 , 67 ), resulted highly over-expressed in PC, suggesting an oncogenic role of this protein in the malignant carcinogenesis of parathyroid tissue and, at the same time, indicating UCH-L1 as a possible distinctive immunohistochemical signature of PC with respect to benign parathyroid tumors. Other promising protein biomarkers, all over-expressed in PCs, were: Malate Dehydrogenase 1 (MDH1), an enzyme that catalyzes the NAD/NADH-dependent reversible oxidation of malate to oxaloacetate in many metabolic pathways and was showed to be up-regulated in cancer ( 68 ); Chloride Intracellular Channel Protein 1 (CLIC1), a protein involved in regulating cell proliferation and differentiation, and metastasis ( 69 , 70 ), and whose up-regulation has previously been associated with human malignancies; and Superoxide Dismutase 2 (SOD2), which is a key player of the antioxidant system of the cell and whose increased expression appears correlated to the stage of tumor progression ( 71 ).…”
Section: Gene Expression Profile and Proteomic Analysis In Parathyroi...mentioning
confidence: 99%